Home » Janssen Gains FDA Approval for Type 2 Diabetes Combo Drug Invokamet XR
Janssen Gains FDA Approval for Type 2 Diabetes Combo Drug Invokamet XR
The FDA approved Janssen’s Invokamet XR, a once-daily combination of canagliflozin and metformin hydrochloride, for use with diet and exercise to improve blood glucose control in adults with type 2 diabetes.
Invokamet XR combines Invokana (canagliflozin) and an extended release formulation of metformin.
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May